| TTM
|
6/30/2026
|
6/30/2025
|
6/30/2024
|
6/30/2023
|
|
|---|---|---|---|---|---|
| Selling, General and Administrative Expenses
|
-6,821.4380 | -6,821.4380 | -4,331.8150 | -2,521.1970 | -2,633.5440 |
|
Research and Development Expenses
|
-73,982.2630 | -73,982.2630 | -70,051.8920 | -56,408.2650 | -35,146.0070 |
| Depreciation, Amortization and Depletion
|
-603.1360 | -603.1360 | -600.0920 | -600.8810 | -551.2180 |
| Other Income/Expense, Operating
|
-1,262.9590 | -1,262.9590 | -934.1960 | -892.3680 | -832.3540 |
|
Operating Income/Expenses
|
-82,669.7960 | -82,669.7960 | -75,917.9950 | -60,422.7110 | -39,163.1230 |
|
Total Operating Profit/Loss
|
-82,669.7960 | -82,669.7960 | -75,917.9950 | -60,422.7110 | -39,163.1230 |
| Total Net Finance Income/Expense
|
13,642.5230 | 13,642.5230 | 2,614.6630 | 746.7670 | 54.5610 |
| Net Investment Income
|
-734.8380 | -734.8380 | -1,204.1890 | -493.8290 | -74.0410 |
| Irregular Income/Expenses
|
-- | -- | -- | -- | 19.8670 |
| Other Income/Expense, Non-Operating
|
25,994.4140 | 25,994.4140 | 23,494.3470 | 22,059.3140 | 15,806.2560 |
|
Non-Operating Income/Expenses, Total
|
38,902.0990 | 38,902.0990 | 24,904.8210 | 22,312.2520 | 15,806.6430 |
|
Pretax Income
|
-43,767.6970 | -43,767.6970 | -51,013.1740 | -38,110.4590 | -23,356.4800 |
|
Provision for Income Tax
|
0 | 0 | 0 | 0 | 0 |
|
Net Income from Continuing Operations
|
-43,767.6970 | -43,767.6970 | -51,013.1740 | -38,110.4590 | -23,356.4800 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-43,767.6970 | -43,767.6970 | -51,013.1740 | -38,110.4590 | -23,356.4800 |
|
Non-Controlling/Minority Interests
|
426.1320 | 426.1320 | 708.4950 | 385.0480 | 567.4950 |
|
Net Income after Non-Controlling/Minority Interests
|
-43,341.5650 | -43,341.5650 | -50,304.6790 | -37,725.4110 | -22,788.9850 |
|
Net Income Available to Common Stockholders
|
-43,341.5650 | -43,341.5650 | -50,304.6790 | -37,725.4110 | -22,788.9850 |
| Basic EPS
|
-0.06 | -0.06 | -0.10 | -0.09 | -0.07 |
| Diluted EPS
|
-0.06 | -0.06 | -0.10 | -0.09 | -0.07 |
|
Basic Weighted Average Shares Outstanding
|
732,562.7510 | 732,562.7510 | 512,515.0430 | 405,244.8070 | 334,500.8560 |
|
Diluted Weighted Average Shares Outstanding
|
732,562.7510 | 732,562.7510 | 512,515.0430 | 405,244.8070 | 334,500.8560 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-57,410.2200 | -57,410.2200 | -53,627.8370 | -38,857.2260 | -23,411.0410 |
|
EBITDA
|
-56,807.0840 | -56,807.0840 | -53,027.7450 | -38,256.3450 | -22,859.8230 |
|
Normalized EBITDA
|
-53,598.8420 | -53,598.8420 | -52,053.7520 | -38,008.9360 | -22,949.9930 |
|
Normalized Income
|
-40,559.4550 | -40,559.4550 | -50,039.1810 | -37,863.0500 | -23,446.6500 |
|
Total Unusual Items
|
3,208.2420 | 3,208.2420 | 973.9930 | 247.4090 | -90.1700 |
|
Total Unusual Items Excluding Goodwill
|
3,208.2420 | 3,208.2420 | 973.9930 | 247.4090 | -90.1700 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
6/30/2023 - 3/29/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade